GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Crescent Biopharma CBIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.65

+0.81%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Fidelity Management & Research Company LLC4.1m39.69%+2.7m31 Dec 2025
BVF Partners L.P.2.7m26.40%+1.4m31 Dec 2025
Fairmount Funds Management LLC2.7m26.39%+1.4m31 Dec 2025
VR Adviser, LLC2.1m20.49%+745.7k31 Dec 2025
Forbion Capital Partners1.7m16.11%+1.7m31 Dec 2025
Vestal Point Capital, LP1.5m14.40%+1.5m31 Dec 2025
Opaleye Management Inc.1.2m11.31%+1.2m31 Dec 2025
Tang Capital Management, LLC872.4k8.38%+172.4k31 Dec 2025
Adar1 Capital Management LLC606k5.82%+606k31 Dec 2025
Logos Global Management LP600k5.76%—31 Dec 2025
The Vanguard Group, Inc.557.5k5.35%−100.4k31 Dec 2025
Boxer Capital Management, LLC453.7k4.36%—31 Dec 2025
Perceptive Advisors LLC453.7k4.36%—31 Dec 2025
Deep Track Capital LP453.7k4.36%—31 Dec 2025
RTW Investments L.P.372.9k3.58%+372.9k31 Dec 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

4.4m

-7.5% on the period before. 12.7 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

68.6%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 24 Sept 20262,299 shares
  • 2 Sept 202642 shares
  • 1 Sept 202642 shares
  • 31 Aug 20261,452 shares
  • 28 Aug 202678 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.